24.50GBp-2.00%Mkt Cap: 16.53M $P/E: Infinity1d ago
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufactu…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap16.53M $
Enterprise Value14.71M $
Revenue (TTM)5.02M $
Gross Profit1.93M $
Net Income (TTM)-1.57M $
Revenue/Share0.0804 USD
Last Price24.50 GBp
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees59
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)Infinity
P/E (Forward)-61.25
PEG—
EV/EBITDA23.53
EV/Revenue2.93
P/S3.29
P/B2.17
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
10.4285% of range27.00
52W High27.00 GBp
52W Low10.42 GBp
Profitability
Gross Margin81.06%
Oper. Margin-8.52%
EBITDA Margin12.45%
Profit Margin-65.72%
ROE-20.05%
ROA-17.63%
Growth
Revenue Growth6.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.44M $
CapEx (TTM)59.78K $
FCF Margin—
FCF Yield—
Net Debt-1.86M $
Net Debt/EBITDA-2.98
Balance Sheet
Debt/Equity0.05
Current Ratio5.92
Quick Ratio4.44
Book Value/Sh0.1130 GBp
Cash/Share0.0380 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 1, 2003
Analyst Consensus
Rating—
Target (Mean)50.00 GBp
Upside (mean)+104.1%
Target Range50.00 GBp – 50.00 GBp
# Analysts1
Ownership
Shares Out.62.06M
Float50.72M
Insiders19.16%
Institutions17.58%
Technical
SMA 5020.64 (+18.7%)
SMA 20015.40 (+59.1%)
Beta0.95
S&P 52W Chg20.25%
Avg Vol (30d)160.13K
Avg Vol (10d)288.06K
Technical Indicators
RSI (14)72.4
MACD1.3807
MACD Signal0.7487
MACD Hist.+0.6321
BB Upper25.80 GBp
BB Middle20.68 GBp
BB Lower15.57 GBp
BB Width49.50%
ATR (14)1.563 GBp
Vol Ratio (20d)0.44x